Consortium exits PregLem in trade sale

The trade sale gives exiting investors an initial cash consideration of CHF 150m and further milestone payments of up to CHF 295m. Richter wholly owns the company following the transaction, which valued PregLem at up to CHF 445m.

The company first received funding in June 2007 and a CHF 36m series-B funding round was completed in December 2007.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Viktor Lundvall on +44 20 7004 7476 or viktor.lundvall@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Exits
• Trade sale
• Switzerland
• Sofinnova